vancomycin has been researched along with Conjunctivitis, Bacterial in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laurent, T; Ledoux, A; Qin, V | 1 |
| Blanco, C; Núñez, MX | 1 |
| Siddiqui, SN; Zafar, SN | 1 |
| Altaş, K; Bağdatli, Y; Bahar, H; Demirci, M; Hiramatsu, K; Kapi, M; Kocazeybek, B; Torun, MM | 1 |
| Cimolai, N | 1 |
| Abate, MA; Ross, J | 1 |
6 other study(ies) available for vancomycin and Conjunctivitis, Bacterial
| Article | Year |
|---|---|
Corynebacterium macginleyi-associated Blebitis: A Case Report.
Topics: Anti-Bacterial Agents; Blister; Conjunctivitis, Bacterial; Corynebacterium; Corynebacterium Infections; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Filtering Surgery; Gentamicins; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Vancomycin | 2018 |
Antibiotic susceptibility of staphylococci isolates from patients with chronic conjunctivitis: including associated factors and clinical evaluation.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Conjunctivitis, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2013 |
Congenital Cataract, Nasolacrimal Duct Obstruction, and Methicillin-Resistant Staphylococcus aureus Conjunctivitis: When to Operate?
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Cataract; Cataract Extraction; Conjunctivitis, Bacterial; Eye Infections, Bacterial; Humans; Infant; Lacrimal Duct Obstruction; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Nasolacrimal Duct; Staphylococcal Infections; Vancomycin | 2016 |
Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study.
Topics: Adult; Aged; Anti-Bacterial Agents; Conjunctivitis, Bacterial; Data Collection; Diabetic Foot; Female; Hospitals, University; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Turkey; Vancomycin | 2005 |
Ocular methicillin-resistant Staphylococcus aureus infections in a newborn intensive care cohort.
Topics: Anti-Bacterial Agents; British Columbia; Chloramphenicol; Conjunctivitis, Bacterial; Disease Outbreaks; Erythromycin; Eye Infections, Bacterial; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Topical vancomycin for the treatment of Staphylococcus epidermidis and methicillin-resistant Staphylococcus aureus conjunctivitis.
Topics: Administration, Topical; Conjunctivitis, Bacterial; Humans; Male; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1990 |